Clinical trial

Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia

NCT00237497 · Takeda, Industry · Completed

Key facts

NCT number NCT00237497
Title Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
Official title A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ramelteon Compared to Placebo With Zopiclone as a Reference Arm in Adults With Chronic Insomnia
Lead sponsor Takeda, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Balance
Intervention type Drug
Interventions Ramelteon, Zopiclone, Placebo
Enrollment 275
Start date Jul 1, 2005
Primary completion Oct 1, 2006
Completion Oct 1, 2006
First posted Oct 12, 2005
Last update posted Feb 2, 2012
Countries United Kingdom

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies